These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23852786)

  • 21. Simultaneous determination of mycophenolic acid and its glucuronides in human plasma using isocratic ion pair high-performance liquid chromatography.
    Mino Y; Naito T; Matsushita T; Kagawa Y; Kawakami J
    J Pharm Biomed Anal; 2008 Feb; 46(3):603-8. PubMed ID: 18164890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasma.
    Westley IS; Sallustio BC; Morris RG
    Clin Biochem; 2005 Sep; 38(9):824-9. PubMed ID: 15963486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sample cleanup-free determination of mycophenolic acid and its glucuronide in serum and plasma using the novel technology of ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
    Kuhn J; Götting C; Kleesiek K
    Talanta; 2010 Mar; 80(5):1894-8. PubMed ID: 20152429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the EMIT Mycophenolic Acid Assay from Dade Behring.
    Vogl M; Weigel G; Seebacher G; Griesmacher A; Laufer G; Müller MM
    Ther Drug Monit; 1999 Dec; 21(6):638-43. PubMed ID: 10604825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
    Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simple reversed-phase ion-pair liquid chromatography assay for the simultaneous determination of mycophenolic acid and its glucuronide metabolite in human plasma and urine.
    Yau WP; Vathsala A; Lou HX; Chan E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(1):101-12. PubMed ID: 15113545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of mycophenolic acid monitoring with PETINIA for prediction of adverse events in kidney transplant recipients.
    Ham JY; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD; Won DI; Song KE; Cho JH
    Scand J Clin Lab Invest; 2016 Jul; 76(4):296-303. PubMed ID: 26981890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable lung transplant recipients.
    Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
    Ann Pharmacother; 2006 Sep; 40(9):1509-16. PubMed ID: 16882870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients.
    Shipkova M; Armstrong VW; Weber L; Niedmann PD; Wieland E; Haley J; Tönshoff B; Oellerich M;
    Ther Drug Monit; 2002 Jun; 24(3):390-9. PubMed ID: 12021631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.
    Musuamba FT; Rousseau A; Bosmans JL; Senessael JJ; Cumps J; Marquet P; Wallemacq P; Verbeeck RK
    Clin Pharmacokinet; 2009; 48(11):745-58. PubMed ID: 19817503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytic validation of the enzyme multiplied immunoassay technique for the determination of mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatographic assay.
    Hosotsubo H; Takahara S; Imamura R; Kyakuno M; Tanaka T; Yazawa K; Hanafusa T; Matsumiya K; Nonomura N; Okuyama A; Sugimoto H
    Ther Drug Monit; 2001 Dec; 23(6):669-74. PubMed ID: 11802102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronopharmacokinetics of mycophenolic acid and its glucuronide and acyl glucuronide metabolites in kidney transplant recipients converted from cyclosporine to everolimus.
    Tedesco-Silva H; Felipe CR; Slade A; Schmouder RL; Medina Pestana JO
    Ther Drug Monit; 2012 Dec; 34(6):652-9. PubMed ID: 23131696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between MPA free fraction and free MPAG concentrations in heart transplant recipients based on simultaneous HPLC quantification of the target compounds in human plasma.
    Cussonneau X; Bolon-Larger M; Prunet-Spano C; Bastien O; Boulieu R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):674-8. PubMed ID: 17350903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liquid chromatographic method for simultaneous determination of mycophenolic acid and its phenol- and acylglucuronide metabolites in plasma.
    Khoschsorur G; Erwa W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(2):355-60. PubMed ID: 14670756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a high pressure liquid chromatography method for the determination of mycophenolic acid and its glucuronide metabolite in small volumes of plasma from paediatric patients.
    Watson DG; Araya FG; Galloway PJ; Beattie TJ
    J Pharm Biomed Anal; 2004 Apr; 35(1):87-92. PubMed ID: 15030883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification by liquid chromatography tandem mass spectrometry of mycophenolic acid and its phenol and acyl glucuronide metabolites.
    Brandhorst G; Streit F; Goetze S; Oellerich M; Armstrong VW
    Clin Chem; 2006 Oct; 52(10):1962-4. PubMed ID: 16931568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPLC determination of mycophenolic acid and mycophenolic acid glucuronide in human plasma with hybrid material.
    Bolon M; Jeanpierre L; El Barkil M; Chelbi K; Sauviat M; Boulieu R
    J Pharm Biomed Anal; 2004 Nov; 36(3):649-51. PubMed ID: 15522544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.
    Figurski MJ; Korecka M; Fields L; Waligórska T; Shaw LM
    Ther Drug Monit; 2009 Dec; 31(6):717-26. PubMed ID: 19809389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-performance liquid chromatography method for the determination of mycophenolic acid and its acyl and phenol glucuronide metabolites in human plasma.
    Patel CG; Akhlaghi F
    Ther Drug Monit; 2006 Feb; 28(1):116-22. PubMed ID: 16418705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Routine Therapeutic Drug Monitoring of Mycophenolic Acid in human Plasma with HPLC-UV and Isotope Dilution LC-MS/MS.
    Paal M; Habler K; Northoff B; Vogeser M
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.